• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of Risk Factors in Patients who presented to the Outpatient Clinic for Breast Cancer-Related Lymphedema.对前往门诊就诊的乳腺癌相关淋巴水肿患者的风险因素评估。
J Breast Health. 2016 Jan 1;12(1):31-36. doi: 10.5152/tjbh.2015.2801. eCollection 2016 Jan.
2
The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.乳腺癌治疗后手臂淋巴水肿的发生率及发生风险因素。
Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.
3
Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.早期乳腺癌术前与淋巴水肿相关的危险因素
Lymphat Res Biol. 2018 Feb;16(1):28-35. doi: 10.1089/lrb.2016.0045. Epub 2017 Mar 27.
4
Systemic analysis on risk factors for breast cancer related lymphedema.乳腺癌相关淋巴水肿危险因素的系统分析。
Asian Pac J Cancer Prev. 2014;15(16):6535-41. doi: 10.7314/apjcp.2014.15.16.6535.
5
Discussion of relationships among changes of pathological indicators, postoperative lymphedema of the upper limb, and prognosis of patients with breast cancer.探讨乳腺癌患者病理指标变化、术后上肢淋巴水肿与预后的关系。
Biosci Rep. 2019 Apr 16;39(4). doi: 10.1042/BSR20190231. Print 2019 Apr 30.
6
Frequency of Early-Stage Lymphedema and Risk Factors in Postoperative Patients with Breast Cancer.乳腺癌术后患者早期淋巴水肿的发生率及危险因素
J Breast Health. 2014 Apr 1;10(2):92-97. doi: 10.5152/tjbh.2014.1973. eCollection 2014 Apr.
7
The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.术后乳腺癌幸存者相关淋巴水肿的发生率和风险因素:一项为期 2 年的随访前瞻性队列研究。
Breast Cancer. 2018 May;25(3):309-314. doi: 10.1007/s12282-018-0830-3. Epub 2018 Feb 3.
8
Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.乳腺癌护理与治疗临床实践指南:11. 淋巴水肿。
CMAJ. 2001 Jan 23;164(2):191-9.
9
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.肥胖是乳腺癌患者术后发生淋巴水肿的一个风险因素。
Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.
10
Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.基于 NCIC CTG MA.20 随机试验的女性乳腺癌腋窝手术后和放疗后淋巴水肿预测列线图的开发和验证。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):165-173. doi: 10.1016/j.ijrobp.2019.05.002. Epub 2019 May 11.

引用本文的文献

1
Predictors of the Efficacy of Lymphedema Decongestive Therapy.淋巴水肿减压治疗疗效的预测因素
Medicina (Kaunas). 2025 Jan 27;61(2):231. doi: 10.3390/medicina61020231.
2
Acquired lymphedema: Molecular contributors and future directions for developing intervention strategies.获得性淋巴水肿:分子影响因素及制定干预策略的未来方向。
Front Pharmacol. 2022 Oct 25;13:873650. doi: 10.3389/fphar.2022.873650. eCollection 2022.
3
Assessment of Potential Risk Factors and Skin Ultrasound Presentation Associated with Breast Cancer-Related Lymphedema in Long-Term Breast Cancer Survivors.长期乳腺癌幸存者中与乳腺癌相关淋巴水肿相关的潜在风险因素及皮肤超声表现评估
Diagnostics (Basel). 2021 Jul 21;11(8):1303. doi: 10.3390/diagnostics11081303.
4
Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.乳腺癌治疗后淋巴水肿与较高体重指数相关:一项系统评价和荟萃分析。
East Afr Health Res J. 2019;3(2):178-192. doi: 10.24248/EAHRJ-D-19-00009. Epub 2019 Nov 29.

本文引用的文献

1
Lymphedema following taxane-based chemotherapy in women with early breast cancer.早期乳腺癌女性接受紫杉烷类化疗后的淋巴水肿
Lymphat Res Biol. 2014 Dec;12(4):282-8. doi: 10.1089/lrb.2014.0030.
2
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.II/III期乳腺癌患者在接受全身化疗和放疗后影响乳腺癌相关淋巴水肿的治疗因素。
Breast Cancer Res Treat. 2014 Nov;148(1):91-8. doi: 10.1007/s10549-014-3137-x. Epub 2014 Sep 25.
3
Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial.物理治疗对乳腺癌相关淋巴水肿的影响:一项多中心、随机、单盲、等效性试验方案
BMC Cancer. 2014 Apr 3;14:239. doi: 10.1186/1471-2407-14-239.
4
Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.乳房和妇科癌症相关的肢体淋巴水肿:诊断方式和治疗选择的综述。
World J Surg Oncol. 2013 Sep 22;11:237. doi: 10.1186/1477-7819-11-237.
5
Risk factors of lymph edema in breast cancer patients.乳腺癌患者淋巴水肿的危险因素。
Int J Breast Cancer. 2013;2013:641818. doi: 10.1155/2013/641818. Epub 2013 Jun 5.
6
Lymphedema of the arm after surgery for breast cancer: new physiotherapy.乳腺癌手术后手臂淋巴水肿:新的物理治疗方法
Clin Exp Obstet Gynecol. 2012;39(4):483-8.
7
Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.巴西东南部某转诊中心行乳腺癌治疗的女性淋巴水肿患病率。
BMC Womens Health. 2013 Feb 13;13:6. doi: 10.1186/1472-6874-13-6.
8
Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials.手法淋巴引流对乳腺癌相关淋巴水肿的影响:一项随机对照试验的系统评价和荟萃分析。
World J Surg Oncol. 2013 Jan 24;11:15. doi: 10.1186/1477-7819-11-15.
9
Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients.通过生物电阻抗测量预测乳腺癌相关淋巴水肿患者的治疗结果。
Ann Rehabil Med. 2011 Oct;35(5):687-93. doi: 10.5535/arm.2011.35.5.687. Epub 2011 Oct 31.
10
Manual lymphatic drainage therapy in patients with breast cancer related lymphoedema.乳腺癌相关淋巴水肿患者的手动淋巴引流治疗。
BMC Cancer. 2011 Mar 9;11:94. doi: 10.1186/1471-2407-11-94.

对前往门诊就诊的乳腺癌相关淋巴水肿患者的风险因素评估。

Assessment of Risk Factors in Patients who presented to the Outpatient Clinic for Breast Cancer-Related Lymphedema.

作者信息

Can Aslı Gençay, Ekşioğlu Emel, Bahtiyarca Zeynep Tuba, Çakcı Fatma Aytül

机构信息

Clinic of Physical Medicine and Rehabilitation, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.

出版信息

J Breast Health. 2016 Jan 1;12(1):31-36. doi: 10.5152/tjbh.2015.2801. eCollection 2016 Jan.

DOI:10.5152/tjbh.2015.2801
PMID:28331728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5351432/
Abstract

OBJECTIVE

Lymphedema is one of the most debilitating outcomes of breast cancer treatment. We aimed to compare the demographic and clinical characteristics of breast cancer patients with and without lymphedema, to assess risk factors for lymphedema, and to evaluate treatment outcomes in lymphedema patients.

MATERIALS AND METHODS

Demographic and clinical characteristics of 84 women with previous surgery for breast cancer who presented to the outpatient clinic between March 2014 and May 2015 were retrospectively extracted from patient records.

RESULTS

Upper extremity lymphedema was detected in 34 of 84 patients (40.5%). The mean age, body mass index, the number of positive lymph nodes and the number of patients with postoperative radiotherapy were significantly higher among patients with lymphedema than those without (p<0.05). Educational level of patients with lymphedema was significantly lower than the other group (p<0.05). The correlation analysis revealed an association between age, educational level, body mass index, tumor stage, number of positive lymph nodes, postoperative radiotherapy and presence of lymphedema. Postoperative radiotherapy was detected as the only independent risk factor by logistic regression analysis. Fourteen out of 26 lymphedema patients were assigned to education, skin care, exercise and compression bandaging therapy. Upper extremity volumes and volume differences were significantly improved after treatment.

CONCLUSION

Advanced age, low educational level, obesity, tumor size, the number of positive lymph nodes and postoperative radiotherapy correlated with the development of lymphedema. Within these factors, postoperative radiotherapy was detected as an independent risk factor for the development of lymphedema. Patient education, skin care, exercise and compression bandage therapy are effective treatment options in breast cancer-related lymphedema.

摘要

目的

淋巴水肿是乳腺癌治疗最使人衰弱的后果之一。我们旨在比较有和没有淋巴水肿的乳腺癌患者的人口统计学和临床特征,评估淋巴水肿的危险因素,并评估淋巴水肿患者的治疗结果。

材料与方法

回顾性地从患者记录中提取了2014年3月至2015年5月期间到门诊就诊的84例曾接受过乳腺癌手术的女性的人口统计学和临床特征。

结果

84例患者中有34例(40.5%)检测出上肢淋巴水肿。淋巴水肿患者的平均年龄、体重指数、阳性淋巴结数量和接受术后放疗的患者数量显著高于无淋巴水肿患者(p<0.05)。淋巴水肿患者的教育水平显著低于另一组(p<0.05)。相关性分析显示年龄、教育水平、体重指数、肿瘤分期、阳性淋巴结数量、术后放疗与淋巴水肿的存在之间存在关联。逻辑回归分析显示术后放疗是唯一的独立危险因素。26例淋巴水肿患者中有14例接受了教育、皮肤护理、运动和加压包扎治疗。治疗后上肢体积和体积差异显著改善。

结论

高龄、低教育水平、肥胖、肿瘤大小、阳性淋巴结数量和术后放疗与淋巴水肿的发生相关。在这些因素中,术后放疗被检测为淋巴水肿发生的独立危险因素。患者教育、皮肤护理、运动和加压绷带治疗是乳腺癌相关淋巴水肿的有效治疗选择。